Sworn Research is proud to offer GLP-3RT, a premium research-grade peptide characterized by its exceptional purity and rigorous quality control standards. Designed specifically for laboratory and scientific applications, this product is intended to support advanced research into multi-receptor metabolic pathways.
Product Overview
GLP-3RT represents the newest class of triple-hormone receptor agonists. Unlike single or dual-receptor analogs, GLP-3RT is engineered to investigate the synergistic effects of simultaneously targeting three distinct key receptors: GLP-1 (Glucagon-like peptide-1), GIP (Glucose-dependent insulinotropic polypeptide), and Glucagon receptors.
This unique “tri-agonist” profile allows researchers to study complex metabolic processes, specifically how the inclusion of glucagon receptor signaling impacts energy expenditure and mitochondrial function alongside standard glucose homeostasis. Sworn Research provides researchers with a stable, lyophilized product suitable for high-precision in vitro and in vivo laboratory protocols.
Our commitment to quality ensures that every vial of GLP-3RT meets a purity standard of greater than 99%, minimizing experimental variables and ensuring reliable, reproducible data.
Key Specifications
-
Product Name: GLP-3RT
-
Quantity: 10mg, or 20mg
-
Format: Lyophilized Powder (freeze-dried in a 3ml glass vial)
-
Purity: ≥ 99% (confirmed via HPLC)
-
Appearance: White to off-white powder
- Mechanism: Triple Agonist (GLP-1 / GIP / Glucagon)
- Recommended Storage: Store refrigerated at 2-8°C upon receipt to maintain stability.
Research Applications
This peptide is intended solely for laboratory research use. Due to its triple-mechanism profile, it is particularly suited for studies focusing on:
-
Thermogenesis & Energy Expenditure: Investigating the role of the glucagon receptor in increasing basal metabolic rate.
-
Hepatic Lipid Metabolism: Studying pathways related to the reduction of liver fat accumulation.
-
Synergistic Metabolic Signaling: Analyzing how the simultaneous activation of GIP, GLP-1, and Glucagon receptors influences insulin sensitivity and glycemic control compared to mono-agonists.
-
GPCR Binding Studies: Assessing receptor affinity across the three distinct targets.
IMPORTANT SAFETY & COMPLIANCE NOTICE This product is sold exclusively for RESEARCH USE ONLY. It is explicitly NOT for human consumption, diagnostic use, or therapeutic procedures in humans or animals. Buyer acknowledges that they are a qualified researcher and will handle this material in accordance with laboratory safety protocols.
